• Stereotactic ablative radiotherapy shows long-term benefit in operable early NSCLC

    3 days ago - By Healio

    Stereotactic ablative radiotherapy appeared as effective as surgery among patients with operable early-stage non-small cell lung cancer, according to results published in The Lancet Oncology.
    Researchers additionally observed minimal adverse events with stereotactic ablative radiotherapy .
    “In 2015, we published a pooled randomized clinical study to compare SABR with surgical lobectomy for stage I NSCLC in The Lancet Oncology. Results of that study showed OS at 3 years was better with SABR compared with surgical resection due to surgery-related mortality and complications,”
    Read more ...